Nasreen Wolcott
Hercules, CANPI 1316176431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.5% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations.
Across 181 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$805
- Pfizer$367
- Lilly USA, LLC$340
- Johnson & Johnson$327
- Novartis$247
- Arcutis Biotherapeutics, Inc.$237
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,45593%
- Education$2417%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $805 |
| Pfizer | 19 | $367 |
| Lilly USA, LLC | 13 | $340 |
| Johnson & Johnson | 9 | $327 |
| Novartis | 11 | $247 |
| Arcutis Biotherapeutics, Inc. | 14 | $237 |
| Amgen | 12 | $233 |
| Incyte Corporation | 8 | $178 |
| Sun Pharmaceutical Industries Inc. | 4 | $175 |
| Sanofi | 7 | $171 |
| LEO Pharma Inc. | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $111 |
| UCB, Inc. | 5 | $111 |
| Dermavant Sciences, Inc. | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $30 |
| Biofrontera Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $16 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 132 | $2,145 |
| Clobetasol Propionate | 39 | $1,537 |
| Fluorouracil | 18 | $1,151 |
| Doxycycline Hyclate | 23 | $837 |
| ValacyclovirValacyclovir Hcl | 16 | $696 |
| Triamcinolone Acetonide | 58 | $695 |
| Betamethasone Dipropionate | 17 | $546 |
| Fluocinonide | 12 | $409 |
| Mupirocin | 33 | $319 |
| Clindamycin Phosphate | 19 | $287 |
| CiclopiroxCiclopirox Olamine | 11 | $272 |
| Hydrocortisone | 30 | $117 |
| Hydroxyzine Hcl | 15 | $105 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.